Noninfective drug-related pneumonitis (DRP) is a well-known adverse effect of several drugs: clinical manifestations have mostly an acute/subacute onset and vary from mild to life-threatening. Several DRP cases have been described in patients receiving anti-tumor necrosis factor α, rituximab, and tocilizumab.1,2 To date, only 4 reports of vedolizumab-related pneumonitis have been presented.3-5.

Pugliese, D., Privitera, G., Schepis, T., Larosa, L., Onali, S., Scaldaferri, F., Gasbarrini, A., Caprioli, F., Armuzzi, A., Drug-Related Pneumonitis in Patients Receiving Vedolizumab Therapy for Inflammatory Bowel Disease, <<CLINICAL GASTROENTEROLOGY AND HEPATOLOGY>>, 2021; (N/A): N/A-N/A. [doi:10.1016/j.cgh.2021.08.041] [http://hdl.handle.net/10807/204153]

Drug-Related Pneumonitis in Patients Receiving Vedolizumab Therapy for Inflammatory Bowel Disease

Pugliese, D.;Privitera, G.;Schepis, T.;Larosa, L.;Onali, S.;Scaldaferri, F.;Gasbarrini, A.;Caprioli, F.;Armuzzi, A.
2021

Abstract

Noninfective drug-related pneumonitis (DRP) is a well-known adverse effect of several drugs: clinical manifestations have mostly an acute/subacute onset and vary from mild to life-threatening. Several DRP cases have been described in patients receiving anti-tumor necrosis factor α, rituximab, and tocilizumab.1,2 To date, only 4 reports of vedolizumab-related pneumonitis have been presented.3-5.
Inglese
Pugliese, D., Privitera, G., Schepis, T., Larosa, L., Onali, S., Scaldaferri, F., Gasbarrini, A., Caprioli, F., Armuzzi, A., Drug-Related Pneumonitis in Patients Receiving Vedolizumab Therapy for Inflammatory Bowel Disease, <<CLINICAL GASTROENTEROLOGY AND HEPATOLOGY>>, 2021; (N/A): N/A-N/A. [doi:10.1016/j.cgh.2021.08.041] [http://hdl.handle.net/10807/204153]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/10807/204153
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 1
  • ???jsp.display-item.citation.isi??? ND
social impact